Nephros Inc

Research Nephros Inc (NEPH) on Bullrun: valuation model: 6.8% overvalued, market cap USD 38.87M, P/E 50.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNEPH
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Valuation signal6.8% overvalued
• Market capUSD 38.87M
• P/E50.7
• Financial periodFY2025
• RevenueUSD 18.79M
• Revenue growth32.7%
• Net incomeUSD 1.19M
• Gross margin61.9%

Valuation Snapshot

Bullrun's latest valuation model marks Nephros Inc as 6.8% overvalued; latest market cap is USD 38.87M; P/E is 50.7.

About Nephros Inc

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.

Frequently asked questions

Is Nephros Inc overvalued or undervalued?

Bullrun's valuation model currently marks Nephros Inc as 6.8% overvalued.

What is Nephros Inc's market cap?

Nephros Inc's market capitalization is USD 38.87M.

What is Nephros Inc's P/E ratio?

Nephros Inc's price-to-earnings (P/E) ratio is 50.7.

What does Nephros Inc do?

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States.